Wolverine Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $85K | Buy |
121,400
+30,700
| +34% | +$16.6K | ﹤0.01% | 5258 |
|
|
2025
Q2 | $49.1K | Sell |
90,700
-29,100
| -24% | -$17.3K | ﹤0.01% | 4348 |
|
|
2025
Q1 | $98.2K | Buy |
119,800
+30,100
| +34% | +$31.9K | ﹤0.01% | 4231 |
|
|
2024
Q4 | $210K | Buy |
+89,700
| New | +$164K | ﹤0.01% | 4462 |
|
|
2023
Q2 | – | Sell |
-20,900
| Closed | -$36K | – | 4863 |
|
|
2023
Q1 | $36K | Buy |
20,900
+5,500
| +36% | +$15.7K | ﹤0.01% | 3899 |
|
|
2022
Q4 | $48K | Sell |
15,400
-3,200
| -17% | -$12.4K | ﹤0.01% | 3590 |
|
|
2022
Q3 | $91K | Sell |
18,600
-4,400
| -19% | -$22.6K | ﹤0.01% | 3956 |
|
|
2022
Q2 | $95K | Buy |
23,000
+700
| +3% | +$3.03K | ﹤0.01% | 3861 |
|
|
2022
Q1 | $132K | Sell |
22,300
-8,900
| -29% | -$52.9K | ﹤0.01% | 4692 |
|
|
2021
Q4 | $244K | Sell |
31,200
-4,500
| -13% | -$39.1K | ﹤0.01% | 4425 |
|
|
2021
Q3 | $326K | Sell |
35,700
-11,200
| -24% | -$111K | ﹤0.01% | 4580 |
|
|
2021
Q2 | $550K | Sell |
46,900
-11,300
| -19% | -$128K | ﹤0.01% | 3553 |
|
|
2021
Q1 | $679K | Sell |
58,200
-57,800
| -50% | -$779K | ﹤0.01% | 3277 |
|
|
2020
Q4 | $1.96M | Buy |
116,000
+69,400
| +149% | +$813K | ﹤0.01% | 1730 |
|
|
2020
Q3 | $461K | Sell |
46,600
-22,900
| -33% | -$248K | ﹤0.01% | 2911 |
|
|
2020
Q2 | $610K | Buy |
69,500
+3,200
| +5% | +$29.7K | ﹤0.01% | 2521 |
|
|
2020
Q1 | $430K | Buy |
66,300
+24,700
| +59% | +$183K | ﹤0.01% | 2830 |
|
|
2019
Q4 | $339K | Buy |
41,600
+7,700
| +23% | +$70.8K | ﹤0.01% | 3450 |
|
|
2019
Q3 | $312K | Sell |
33,900
-48,100
| -59% | -$540K | ﹤0.01% | 3122 |
|
|
2019
Q2 | $883K | Sell |
82,000
-27,700
| -25% | -$295K | ﹤0.01% | 2165 |
|
|
2019
Q1 | $1.05M | Sell |
109,700
-75,000
| -41% | -$766K | ﹤0.01% | 2032 |
|
|
2018
Q4 | $2.01M | Sell |
184,700
-15,200
| -8% | -$189K | 0.01% | 1414 |
|
|
2018
Q3 | $3.39M | Buy |
199,900
+55,700
| +39% | +$847K | 0.01% | 1238 |
|
|
2018
Q2 | $2.74M | Hold |
144,200
| – | – | 0.01% | 1322 |
|
|
2018
Q1 | $2.74M | Buy |
144,200
+35,000
| +32% | +$748K | 0.01% | 1322 |
|
|
2017
Q4 | $1.79M | Sell |
109,200
-14,100
| -11% | -$210K | 0.01% | 1644 |
|
|
2017
Q3 | $1.85M | Buy |
123,300
+53,600
| +77% | +$593K | 0.01% | 1382 |
|
|
2017
Q2 | $620K | Buy |
69,700
+25,700
| +58% | +$165K | ﹤0.01% | 2218 |
|
|
2017
Q1 | $207K | Buy |
44,000
+4,000
| +10% | +$16K | ﹤0.01% | 3492 |
|
|
2016
Q4 | $122K | Sell |
40,000
-11,800
| -23% | -$43K | ﹤0.01% | 3985 |
|
|
2016
Q3 | $237K | Sell |
51,800
-41,800
| -45% | -$213K | ﹤0.01% | 3582 |
|
|
2016
Q2 | $540K | Buy |
+93,600
| New | +$597K | ﹤0.01% | 2161 |
|
Other funds holding SGMO
GCP
Wolverine Trading's SGMO Position: Q3 2025 in Review
Wolverine Trading opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q3 2025: 23,799 shares worth $16.7K. The stake represents ﹤0.01% of the portfolio and ranks #5547 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in SGMO as recently as Q1 2025.
Wolverine Trading first reported a position in SGMO in Q2 2016 and has held it in 21 quarters since. The position peaked at $1.69M in Q4 2018. 112 funds tracked by Wall St. Rank hold SGMO as of Q3 2025.
- Wolverine Trading held 23,799 shares of SANGAMO THERAPEUTICS INC worth $16.7K as of Q3 2025.
- SANGAMO THERAPEUTICS INC was a new Wolverine Trading position in Q3 2025.
- SANGAMO THERAPEUTICS INC made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5547 holding.
- Wolverine Trading first reported a position in SANGAMO THERAPEUTICS INC in Q2 2016 and has held it in 21 quarters since.
- Wolverine Trading's SANGAMO THERAPEUTICS INC position peaked at $1.69M in Q4 2018.
- 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.